Stephen Dilly, new Codexis president and CEO
July 19, 2022 09:10 AM EDT
People

Short­ly af­ter sell­ing Sier­ra to GSK, Stephen Dil­ly heads to en­zyme en­gi­neer Codex­is as new CEO

Kyle LaHucik

Senior Reporter

On Feb. 22, Stephen Dil­ly had no clear am­bi­tions of sell­ing Sier­ra On­col­o­gy to GSK. But that quick­ly changed over the sub­se­quent weeks, and …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Three drug­mak­ers sue US over 340B dis­counts to STD clin­ics they al­lege don’t qual­i­fy

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

Deer­field wins fight to ac­quire Sin­gu­lar Ge­nomics, beat­ing out Tang Cap­i­tal’s Con­cen­tra

Ver­tex gets 'van­za triple' ap­proval and Trikaf­ta ex­pan­sion — with boxed warn­ings

A service from the Financial Times